Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-062647

Director bought 420 shares at an average $2.37 ($996)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2022-11-01 Purchase +20 $2.53 $51 18,808 D
Young Caroline Director 2022-11-02 Purchase +20 $2.54 $51 18,828 D
Young Caroline Director 2022-11-03 Purchase +20 $2.44 $49 18,848 D
Young Caroline Director 2022-11-04 Purchase +20 $2.42 $48 18,868 D
Young Caroline Director 2022-11-07 Purchase +20 $2.45 $49 18,888 D
Young Caroline Director 2022-11-08 Purchase +20 $2.42 $48 18,908 D
Young Caroline Director 2022-11-09 Purchase +20 $2.37 $47 18,928 D
Young Caroline Director 2022-11-10 Purchase +20 $2.37 $47 18,948 D
Young Caroline Director 2022-11-11 Purchase +20 $2.32 $46 18,968 D
Young Caroline Director 2022-11-14 Purchase +20 $2.32 $46 18,988 D
Young Caroline Director 2022-11-15 Purchase +20 $2.35 $47 19,008 D
Young Caroline Director 2022-11-16 Purchase +20 $2.31 $46 19,028 D
Young Caroline Director 2022-11-17 Purchase +20 $2.29 $46 19,048 D
Young Caroline Director 2022-11-18 Purchase +20 $2.27 $45 19,068 D
Young Caroline Director 2022-11-21 Purchase +20 $2.38 $48 19,088 D
Young Caroline Director 2022-11-22 Purchase +20 $2.37 $47 19,108 D
Young Caroline Director 2022-11-23 Purchase +20 $2.29 $46 19,128 D
Young Caroline Director 2022-11-25 Purchase +20 $2.31 $46 19,148 D
Young Caroline Director 2022-11-28 Purchase +20 $2.37 $47 19,168 D
Young Caroline Director 2022-11-29 Purchase +20 $2.34 $47 19,188 D
Young Caroline Director 2022-11-30 Purchase +20 $2.32 $46 19,208 D
Open-market purchases · 420 sh · avg $2.37 · $996
Loading xslF345X03/doc4.xml…